- Investing.com
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Metrics to compare | NDRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNDRAPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.5x | −3.4x | −0.6x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 0.6x | 3.0x | 2.6x | |
Price / LTM Sales | - | 4.1x | 3.1x | |
Upside (Analyst Target) | 138,788.9% | 73.2% | 58.1% | |
Fair Value Upside | Unlock | 9.0% | 9.2% | Unlock |